Seinda Corporation is dedicated to advancing global eye health through scientific innovation and a patient-centered approach. As the parent company of Seinda Pharmaceutical Corp. and Seinda Biomedical Corp., we are committed to developing breakthrough therapeutics and precision diagnostics for ocular diseases with unmet needs.
Seinda Pharmaceutical is a clinical-stage, science-driven company focused on pioneering new treatments for dry eye disease (DED) and other ocular conditions. Our lead candidate, SY-201, a novel small peptide therapeutic, has demonstrated proof-of-concept in a U.S. Phase 2 clinical trial and is now progressing into Phase 3 trials in both the U.S. and China.
Seinda Biomedical, founded in 2015, specializes in tear-based biomarker point-of-care tests that enable precision eye care. Through our proprietary i-ImmunDx™ platform, we have developed highly sensitive, accurate, and user-friendly diagnostic tools—including the LTa3-POC, IgE-POC, MMP9-POC, and IL6-POC tests—designed to support better patient stratification, disease severity assessment, and treatment selection in DED.
At Seinda, we believe that innovation and collaboration can transform the future of ocular health.
For mor information, please email info@seindabio.com or check out our website at www.seindabio.com.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Gz International Bio-Island, Guangzhou,guangdong,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.seindabio.com
- Keywords
- Biotech R & D, Ophthalmic New Drug Development, Tear Biomarker Tests, Diagnostics, Pharmaceutical, Precision Medicine, ocular health.
- HQ
- Guangzhou, Guangdong
Seinda Corporation Questions
Seinda Corporation's website is http://www.seindabio.com
Seinda Corporation's LinkedIn profile is https://cn.linkedin.com/company/seindacorp
Seinda Corporation has
3 employees.
View email and phone details for 3
employees at Seinda Corporation.
Seinda Corporation's industry is
Biotechnology Research
Seinda Corporation's top competitors are
Oculis,
Kiora Pharmaceuticals, Inc.,
Aurion Biotech,
Ocular Therapeutix, Inc.,
Stuart Therapeutics,
Aura Biosciences,
Novaliq Gmbh,
Mediprint Ophthalmics,
Viridian Therapeutics, Inc.,
Eye-Go A/s.
Seinda Corporation's categories are Biotechnology Research
Seinda Corporation's founding year is 2015
